Clinical research
Participants newly diagnosed with type 2 diabetes will be randomized 1:1 to Routine Care (RC) or Routine Care + Glycemic Excursion Minimization (RC+GEM). Participants will participate for up to 13.5 months and will be provided with a CGM and Fitbit. RC+GEM participants will complete a 6-week GEM intervention. Primary outcomes include A1c and current diabetes medications. We anticipate that RC+GEM will: 1) reduce hemoglobin A1c as much or more, 2) require less diabetes medication, 3) cost less, and 4) have more secondary benefits, (e.g. greater reduction in cardiovascular risk, weight, diabetes distress, depression symptoms), compared to RC alone.
References
Up to 50% of adults with type 2 diabetes do not meet glycemic targets despite the continued development of new pharmacologic interventions. The addition of lifestyle and empowerment programs such as GEM have the potential to improve clinical and psychosocial outcomes while reducing healthcare costs.
GEM reduces glucose elevations with lower carbohydrate intake, hastens blood glucose recovery by increased physical activity, and increases diabetes empowerment while reducing diabetes distress and depressive symptoms. This has contributed to relatively long-term (13 months) follow-up benefits with no booster intervention.
Coming soon.